Cookie usage policy

The website of the University Carlos III of Madrid use its own cookies and third-party cookies to improve our services by analyzing their browsing habits. By continuing navigation, we understand that it accepts our cookie policy. "Usage rules"


Renewal of the UC3M-CIEMAT Biomedical Engineering Joint Unit

The university and the public research organisation continue their R+D+I collaboration


The Universidad Carlos III de Madrid (UC3M) and the Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT, its Spanish acronym) have renewed their joint research, development and innovation plan in the field of Biomedical Engineering through the UC3M-CIEMAT Joint Unit, which focuses on the fields of Tissue Engineering, Regenerative Epithelial Medicine and the integration between biomedicine and engineering (Integrative Biomedicine).

The collaboration agreement for maintaining this unit has been signed by Juan Romo, president of the UC3M, and by Carlos Alejaldre Losilla, general director of the CIEMAT, in an event held yesterday, Thursday, on the University’s Getafe Campus, with the researchers of that field from both institutions in attendance.

Within the framework of this agreement, the research staff of the UC3M and the CIEMAT will be able to collaborate on national and international scientific projects, share their facilities and equipment, carry out activities of knowledge and scientific results transfer, train researchers in the field of integrative biomedicine and organise joint activities to promote and spread scientific culture. In addition, UC3M students can choose to undertake internship programmes and carry out their dissertations, final master’s projects and doctoral thesis in the CIEMAT facilities.

The lines of research developed by this UC3M-CIEMAT Joint Unit are very diverse: from genetic diagnosis and Epidermolysis Bullosa treatment to gene editing for the treatment of diseases using CRISPR/Cas9 technology, through the 3D bioprinting of tissues and organs or the development of new advanced instrumental and material techniques for modelling, diagnosing and treating the most common diseases, among others.

The UC3M-CIEMAT Joint Unit is formed of various groups of researchers from both organisations. On one hand, the Unidad de Modelización de Enfermedades Cutáneas (Skin Disease Modelling Unit), led by Fernando Larcher, CIEMAT researcher. On the other hand, the Unidad de Medicina Regenerativa CIEMAT-CIBER de Enfermedades Raras (CIEMAT-CIBER Rare Disease Regenerative Medicine Unit), the manager of which is Marcela del Río from the Epithelial Biomedicine Division of the CIEMAT Department of Basic Research and lecturer from the UC3M’s Bioengineering and Aerospace Engineering Department. Finally, the UC3M’s Integrative Biomedicine group, led by José Luis Jorcano, lecturer from the University’s Bioengineering and Aerospace Engineering Department.